Publisher
Springer Science and Business Media LLC
Reference86 articles.
1. Friedman JM. Neurofibromatosis 1. 1998 Oct [Updated 2019]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews. Seattle: University of Washington, Seattle; 1993-2020.
2. • Miller DT, Freedenberg D, Schorry E, Ullrich NJ, Viskochil D, Korf BR, et al. Health supervision for children with neurofibromatosis type 1. Pediatrics. 2019;143(5):e20190660 An overview of evidence based recommendations for the evaluation and management of NF1-related pathology.
3. Kehrer-Sawatzki H, Mautner V-F, Cooper DN. Emerging genotype–phenotype relationships in patients with large NF1 deletions. Hum Genet. 2017;136(4):349–76.
4. • Markham A, Keam SJ. Selumetinib: first approval. Drugs. 2020;80(9):931–7 An overview of the PK and PD properties of Selumetinib.
5. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献